The emergency caused by Covid-19 pandemic raised interest in studying lifestyles and comorbidities as important determinants of poor Covid-19 prognosis. Data on tobacco smoking, alcohol consumption and obesity are still limited, while no data are available on the role of e-cigarettes and heated tobacco products (HTP). To clarify the role of tobacco smoking and other lifestyle habits on COVID-19 severity and progression, we designed a longitudinal observational study titled COvid19 and SMOking in ITaly (COSMO-IT). About 30 Italian hospitals in North, Centre and South of Italy joined the study. Its main aims are: 1) to quantify the role of tobacco smoking and smoking cessation on the severity and progression of COVID-19 in hospitalized patients; 2) to compare smoking prevalence and severity of the disease in relation to smoking in hospitalized COVID-19 patients versus patients treated at home; 3) to quantify the association between other lifestyle factors, such as e-cigarette and HTP use, alcohol and obesity and the risk of unfavourable COVID-19 outcomes. Socio-demographic, lifestyle and medical history information will be gathered for around 3000 hospitalized and 700-1000 home-isolated, laboratory-confirmed, COVID-19 patients. Given the current absence of a vaccine against SARS-COV-2 and the lack of a specific treatment for -COVID-19, prevention strategies are of extreme importance. This project, designed to highly contribute to the international scientific debate on the role of avoidable lifestyle habits on COVID-19 severity, will provide valuable epidemiological data in order to support important recommendations to prevent COVID-19 incidence, progression and mortality.
Covid-19 and the role of smoking: the protocol of the multicentric prospective study COSMO-IT (COvid19 and SMOking in ITaly) / Cattaruzza, Maria Sofia; Gorini, Giuseppe; Bosetti, Cristina; Boffi, Roberto; Lugo, Alessandra; Veronese, Chiara; Carreras, Giulia; Santucci, Claudia; Stival, Chiara; Pacifici, Roberta; Zagà, Vincenzo; Gallus, Silvano; Giulietti, Federico; Sarzani, Riccardo; Spannella, Francesco; Del Donno, Mario; Tartaglione, Stefania; Marrazzo, Giuseppina; Pelaia, Girolamo; D'Agosto, Vincenzo; Berti, Alice; Voller, Fabio; Cardellicchio, Salvatore; Cresci, Chiara; Foschino Barbaro, Maria Pia; De Palma, Raffaele; Negrini, Simone; Sicbaldi, Vera; Serafini, Antonella; Bisconti, Mario; Refolo, Leonida; Landoni, Giovanni; Rovere, Patrizia; Veronesi, Giulia; Faverio, Paola; Garavello, Werner; Pesci, Alberto; Giacobbe, Raffaella; Martucci, Paola; Parrella, Roberto; Scarano, Francesco; Aiello, Marina; Chetta, Alfredo; Franco, Cosimo; Mangia, Angelo; Carrozzi, Laura; Maggi, Fabrizio; Monzani, Fabio; Pistelli, Francesco; Russo, Patrizia; Sanna, Antonio; Barreca, Filippo Maria; Conti, Valentina; Rossi, Enrico; Ruli, Mei; Ruli, Silvana; Eslami Varzaneh, Shokoofe; Principe, Rosastella; Guerrini, Simone; Sebastiani, Alfredo; Galluccio, Giovanni; Pezzuto, Aldo; Ricci, Alberto; Casali, Elena; Mastroianni, Claudio; Pirina, Pietro; Polo, Francesca; Beatrice, Fabio; Romagnoli, Micaela; Baraldo, Massimo; Cojutti, Pier Giorgio; Tascini, Carlo; Pecori, Davide; Graziano, Elena; Tinghino, Biagio. - In: ACTA BIOMEDICA. - ISSN 2531-6745. - 91:3(2020), p. e2020062. [10.23750/abm.v91i3.10373]
Covid-19 and the role of smoking: the protocol of the multicentric prospective study COSMO-IT (COvid19 and SMOking in ITaly)
Landoni, Giovanni;Rovere, Patrizia;Veronesi, Giulia;
2020-01-01
Abstract
The emergency caused by Covid-19 pandemic raised interest in studying lifestyles and comorbidities as important determinants of poor Covid-19 prognosis. Data on tobacco smoking, alcohol consumption and obesity are still limited, while no data are available on the role of e-cigarettes and heated tobacco products (HTP). To clarify the role of tobacco smoking and other lifestyle habits on COVID-19 severity and progression, we designed a longitudinal observational study titled COvid19 and SMOking in ITaly (COSMO-IT). About 30 Italian hospitals in North, Centre and South of Italy joined the study. Its main aims are: 1) to quantify the role of tobacco smoking and smoking cessation on the severity and progression of COVID-19 in hospitalized patients; 2) to compare smoking prevalence and severity of the disease in relation to smoking in hospitalized COVID-19 patients versus patients treated at home; 3) to quantify the association between other lifestyle factors, such as e-cigarette and HTP use, alcohol and obesity and the risk of unfavourable COVID-19 outcomes. Socio-demographic, lifestyle and medical history information will be gathered for around 3000 hospitalized and 700-1000 home-isolated, laboratory-confirmed, COVID-19 patients. Given the current absence of a vaccine against SARS-COV-2 and the lack of a specific treatment for -COVID-19, prevention strategies are of extreme importance. This project, designed to highly contribute to the international scientific debate on the role of avoidable lifestyle habits on COVID-19 severity, will provide valuable epidemiological data in order to support important recommendations to prevent COVID-19 incidence, progression and mortality.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
